GlassScriptPhysician profile
Raj Shah
NPI 1154749216
$29,344.50
in general payments reported to CMS, 2019-2025
15 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $67.00 · 2021: $60.19 · 2022: $14K · 2023: $14K · 2024: $654 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Food and Beverage: $2,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Food and Beverage | $2,167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,576.05 | 2022-2025 | Axios, Orbera Intragastric Balloon System, General - Therapies |
| Olympus Corporation of The Americas | $1,329.36 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $399.33 | 2023-2024 | Fujifilm, Arietta Precision |
| Medtronic, INC. | $215.62 | 2022 | |
| Olympus America INC. | $118.97 | 2023 | Hanarostent Lowaxtm Duodenum/Pylorus(Nnn) |
| Pfizer INC. | $108.57 | 2019 | |
| Novo Nordisk INC | $108.38 | 2023 | Wegovy |
| Lilly USA, LLC | $106.35 | 2024 | Omvoh |
| Shionogi INC | $100.23 | 2019 | |
| Abbvie INC. | $82.99 | 2019 | |
| Intercept Pharmaceuticals, INC. | $60.19 | 2021 | |
| Ardelyx, INC. | $48.90 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $37.90 | 2020 | |
| Merck Sharp & Dohme LLC | $29.10 | 2020 | |
| Apollo Endosurgery US INC | $22.56 | 2023 | Overstitch Endoscopic Suturing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.